Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Dimetris Roubis

Physician Assistant New Hyde Park, NY Physician Assistant

NPI 1427074756 CMS profile 10930717

1 Hollow Ln, Suite 110-North Shore Allergy & Asthma Institute, New Hyde Park, NY 11042

Open in the dashboard

General payments

$18,160

743 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dimetris Roubis of New Hyde Park, NY is reported in the CMS Open Payments database as having received $18,160 across 743 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,936 164
2024 General $3,638 145
2023 General $4,637 155
2022 General $3,787 160
2021 General $2,163 119

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dimetris Roubis
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Dimetris Roubis were reported at $3,936. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Dimetris Roubis Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,163 $132 $37–$438 $132
2022 $3,787 $155 $48–$522 $149
2023 $4,637 $167 $52–$557 $160
2024 $3,638 $178 $55–$600 $164
2025 $3,936 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. GlaxoSmithKline, LLC. $2,907 143 payments
  2. Regeneron Healthcare Solutions, Inc. $2,577 91 payments
  3. Genzyme Corporation $1,617 57 payments
  4. AstraZeneca Pharmaceuticals LP $1,592 62 payments
  5. Pfizer Inc. $1,105 44 payments
  6. Novartis Pharmaceuticals Corporation $1,016 43 payments
  7. OptiNose US, Inc. $965 32 payments
  8. Amgen Inc. $946 31 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $916 38 payments
  10. Grifols USA, LLC $569 23 payments
  11. Other $3,950 179 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $17,907 739 payments
  2. Education $253 4 payments
Products named General payments · program years 2021–2025
  1. DUPIXENT Immunology $2,765 98 payments
  2. DUPIXENT Inflammation And Immunology $1,822 64 payments
  3. NUCALA $1,490 65 payments
  4. TRELEGY ELLIPTA $1,403 77 payments
  5. Xhance $965 32 payments
  6. TEZSPIRE Inflammation $847 27 payments
  7. CUVITRU $827 34 payments
  8. TEZSPIRE Respiratory $798 27 payments
  9. DUPIXENT Immunology And Inflammation $755 27 payments
  10. CIBINQO $573 23 payments
  11. Other $8,164 358 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

743 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record